Eligibility

If you have been diagnosed with symptomatic mitral regurgitation (MR), you may be eligible for the APOLLO Trial.

CAUTION: The Intrepid™ transcatheter mitral valve replacement system is an investigational device. Limited by federal (United States) law to investigational use. Exclusively for clinical investigations. Not approved by FDA and not for sale in the United States.

CAUTION: Investigational device. To be used by qualified investigators only. Exclusively for clinical investigations.

Male doctor in white lab coat sitting next to a female patient in purple shirt looking at a tablet

Alert Important Safety Information

Who is eligible to participate?

You may be eligible if:

You have moderate to severe or severe symptomatic mitral regurgitation.
You have moderate symptomatic mitral regurgitation combined with mitral stenosis in the presence of mitral annular calcification (MAC).
Your doctor thinks you are a candidate for bioprosthetic mitral valve replacement.
Your doctor thinks you are unsuitable for surgery or other approved transcatheter mitral valve repair.

You are not eligible if:

Your doctor does not recommend the procedure for you.

I want to participate in the APOLLO Trial. What should I do next?

The next thing to do is speak with your doctor and ask for more information about the APOLLO Trial, or contact an APOLLO Trial center to learn more.

Find a clinical trial location.

Browse a list of our APOLLO Trial locations to find the one nearest to you.

See APOLLO Trial locations